154 related articles for article (PubMed ID: 3499543)
21. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
Bigda J; Mysliwska J; Baran W; Hellmann A; Mysliwski A
Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
[TBL] [Abstract][Full Text] [Related]
22. The U.K. experience with human lymphoblastoid interferon in HCL: a report of the first 50 cases.
Worman CP; Catovsky D; Cawley JC; Bevan PC; Bottomley JM; Nethersell AB
Leukemia; 1987 Apr; 1(4):320-2. PubMed ID: 3669754
[TBL] [Abstract][Full Text] [Related]
23. Plasma levels of soluble CD8 antigen and interleukin-2 receptor antigen in patients with hairy cell leukemia, relationship with splenectomy and with clinical response to therapy.
Ho AD; Grossmann M; Knauf W; Martin H; Trümper L; Zwingers T; Sonnen R; Pralle H; Hunstein W
Leukemia; 1989 Oct; 3(10):718-23. PubMed ID: 2506398
[TBL] [Abstract][Full Text] [Related]
24. Hairy cell leukemia: a model for studying the B cell family of diseases.
Al-Katib A; Berman E; Black P; Koziner B
Semin Oncol; 1986 Dec; 13(4 Suppl 5):48-54. PubMed ID: 3492047
[TBL] [Abstract][Full Text] [Related]
25. Modulation of immune functions by long-term treatment with recombinant interferon-alpha 2 in a patient with hairy-cell leukemia.
Teichmann JV; Sieber G; Ludwig WD; Ruehl H
J Interferon Res; 1988 Feb; 8(1):15-24. PubMed ID: 3259251
[TBL] [Abstract][Full Text] [Related]
26. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia.
Bardawil RG; Ratain MJ; Golomb HM; Bitter MA; Groves C; Vardiman JW
Leukemia; 1987 Apr; 1(4):340-3. PubMed ID: 3669760
[TBL] [Abstract][Full Text] [Related]
27. Hairy cells possess more interferon receptors than other lymphoid cell types.
Dadmarz R; Evans T; Secher D; Marshall N; Cawley JC
Leukemia; 1987 Apr; 1(4):357-61. PubMed ID: 2959825
[TBL] [Abstract][Full Text] [Related]
28. Strategy for the treatment of hairy cell leukemia.
Porzsolt F; Raghavachar A; Digel W; Raghavachar A; Bartram CR; Heimpel H
Leukemia; 1987 Apr; 1(4):334-7. PubMed ID: 3669758
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of hairy-cell leukemia using interferon alfa].
Neuwirtová R; Cermák J; Kvasnicka J; Sedlácková M
Cas Lek Cesk; 1989 Aug; 128(34):1065-70. PubMed ID: 2790914
[TBL] [Abstract][Full Text] [Related]
30. [Use of alpha-interferon in the treatment of patients with hairy cell leukemia].
Gotić M; Rolović Z; Vuković S; Elezović I; Tomić D
Srp Arh Celok Lek; 1990; 118(7-8):277-84. PubMed ID: 2097776
[TBL] [Abstract][Full Text] [Related]
31. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
[TBL] [Abstract][Full Text] [Related]
32. Recombinant alpha-interferon (alpha-IFN) for progressive hairy-cell leukemia (HCL): a study in previously untreated nonsplenectomized patients.
Schwarzinger I; Bettelheim P; Chott A; Herold C; Hinterberger W; Köller U; Kos M; Neumann E; Radaszkiewicz T; Lechner K
Wien Klin Wochenschr; 1988 Jan; 100(2):47-51. PubMed ID: 3348041
[TBL] [Abstract][Full Text] [Related]
33. Peripheral blood lymphocyte subsets and natural killer cell number and function during alpha-interferon treatment for hairy cell leukemia.
Gibson J; Gallagher K; Cameron K; Basten A; Gatenby P; Joshua D; Kronenberg H
Aust N Z J Med; 1988 Dec; 18(7):897-9. PubMed ID: 3074762
[No Abstract] [Full Text] [Related]
34. Interferon alpha-2 for hairy cell leukemia: evidence for induction of RNA synthesis in hairy cells and failure to correlate enhancement of natural killer cells with elimination of hairy cells.
Schwarzmeier JD; Schwabe M; Prischl F; Wagner L; Lion T; Micksche M; Köller U
Eur J Haematol; 1987 Nov; 39(5):418-25. PubMed ID: 3691760
[TBL] [Abstract][Full Text] [Related]
35. Changes in hairy cells after alpha-interferon treatment as measured by flow cytometry.
Huang AT; Mold NG
Leukemia; 1987 Apr; 1(4):308-11. PubMed ID: 3669751
[TBL] [Abstract][Full Text] [Related]
36. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
Gastl G; Werter M; De Pauw B; Nerl C; Aulitzky W; von Lüttichau I; Tilg H; Thaler J; Lang A; Abbrederis K
Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
[TBL] [Abstract][Full Text] [Related]
37. Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.
Aderka D; Levo Y; Rahmani R; Mory Y; Vaks B; Horowitz O; Doerner T; Shoham J; Wallach D; Revel M
Isr J Med Sci; 1985 Dec; 21(12):977-81. PubMed ID: 4093298
[TBL] [Abstract][Full Text] [Related]
38. Hairy cell leukemia: an interferon deficient disease?
Hofmann V; Fehr J; Sauter C; Ottino J
Cancer Treat Rev; 1985 Dec; 12 Suppl B():33-7. PubMed ID: 3833328
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia.
Trentin L; Zambello R; Agostini C; Ambrosetti A; Chisesi T; Raimondi R; Bulian P; Pizzolo G; Semenzato G
Blood; 1990 Apr; 75(7):1525-30. PubMed ID: 2317560
[TBL] [Abstract][Full Text] [Related]
40. [Therapeutic effect of interferon-alpha on hairy cell leukemia].
Abe Y; Sakai K; Igarashi T; Ishibashi T; Shiga T; Uchida T; Kariyone S
Rinsho Ketsueki; 1989 Apr; 30(4):535-40. PubMed ID: 2769975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
